Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03440918 · ClinicalTrials.gov registry record · NA

Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
271
Enrollment target

NCT03440918 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 271 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03440918, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
271 participants
Enrollment target

Study Summary

The timely use of antibiotics can reduce morbidity and mortality associated with bacterial infections, particularly in the intensive care unit setting (ICU). Long courses of antibiotics, however, are associated with the emergence of multi-drug resistant organisms and antibiotic-associated adverse events, such as C. difficile infections. Thus, antibiotic de-escalation is an important goal of antimicrobial stewardship programs. Procalcitonin (PCT) has been investigated as a biomarker for critically ill adult patients with bacterial infection, particularly pneumonia and sepsis. The proposed project will evaluate whether a PCT testing and treatment algorithm, implemented through daily antimicrobial stewardship audit and feedback, can promote early and safe antibiotic de-escalation in the pediatric ICU.

Interventions

  • OTHER Procalcitonin-Guided Antimicrobial Stewardship
  • OTHER Baseline Antimicrobial Stewardship

Trial Details

FieldValue
Enrollment Target 271 participants
Start Date 2018-02-12
Est. Completion 2019-05-11
Phase NA

What the Registry Record Tells You About NCT03440918

The ClinicalTrials.gov registry entry for NCT03440918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Procalcitonin-Guided Antimicrobial Stewardship is the first listed.

NCT03440918 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03440918 about?

NCT03440918 is a clinical study titled "Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit". The timely use of antibiotics can reduce morbidity and mortality associated with bacterial infections, particularly in the intensive care unit setting (ICU). Long courses of antibiotics, however, are associated with the emergence of multi-drug resistant organisms and antibiotic-associated adverse ev...

What is the current status of trial NCT03440918?

This trial is currently completed. It is a NA study. The enrollment target is 271 participants. The study started on 2018-02-12. Estimated completion is 2019-05-11.

What interventions are being tested in trial NCT03440918?

The interventions under investigation include: Procalcitonin-Guided Antimicrobial Stewardship (OTHER), Baseline Antimicrobial Stewardship (OTHER).

Who is sponsoring clinical trial NCT03440918?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.